2020
DOI: 10.20944/preprints202006.0326.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Investigating Potential Inhibitory Effect of <em>Uncaria tomentosa</em> (Cat's claw) against the Main Protease 3CL<sup>Pro</sup> of SARS-CoV-2 by Molecular Modeling

Abstract: COVID-19 is a novel severe acute respiratory syndrome coronavirus. Presently, there is no effective treatment for COVID-19. As part of the worldwide efforts to find efficient therapies and preventions, it has been reported the crystalline structure of the SARS-CoV-2 main protease Mpro (also called 3CLpro) bound to a synthetic inhibitor which represents a major druggable target. The druggability of Mpro could be used for discovering drugs to treat coronavirus disease 2019. It was carried out a multi-level compu… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 52 publications
0
1
0
Order By: Relevance
“…ex Schult.) DC, known as cat's claw, exhibits 3CLPro inhibitory activity as found by molecular docking analysis (Yepes-Pérez et al, 2020). Isolated phytochemicals such as cadambine, speciophylline, and proanthocyanidin of Uncaria tomentosa effectively interacted with 3CLpro.…”
Section: Inhibition Of Sars-cov Mpro Plpro 3clpro and Related Proteasesmentioning
confidence: 90%
“…ex Schult.) DC, known as cat's claw, exhibits 3CLPro inhibitory activity as found by molecular docking analysis (Yepes-Pérez et al, 2020). Isolated phytochemicals such as cadambine, speciophylline, and proanthocyanidin of Uncaria tomentosa effectively interacted with 3CLpro.…”
Section: Inhibition Of Sars-cov Mpro Plpro 3clpro and Related Proteasesmentioning
confidence: 90%